Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

P2ry10 Inhibitors

P2ry10 inhibitors are a class of chemical compounds that specifically target and inhibit the P2ry10 receptor, a member of the purinergic receptor family, which is part of the G-protein-coupled receptor (GPCR) superfamily. P2ry10 is involved in cellular communication by responding to extracellular lysophospholipids, particularly lysophosphatidic acid (LPA) and sphingosine-1-phosphate (S1P). These signaling molecules are essential for regulating a variety of cellular processes, including cell migration, proliferation, and intracellular signaling pathways. The P2ry10 receptor mediates its effects by activating intracellular G-proteins, which then initiate downstream signaling cascades that influence cell behavior. Inhibitors of P2ry10 function by preventing these ligands from binding to the receptor, thereby blocking the signaling pathways that are normally activated in response to extracellular signals.

Researchers use P2ry10 inhibitors to study the precise role of this receptor in lysophospholipid signaling and its broader effects on cellular functions. By inhibiting P2ry10, scientists can explore how the disruption of this receptor's activity affects cellular processes such as chemotaxis, cytoskeletal reorganization, and cell-to-cell communication. P2ry10 inhibitors also provide insights into how lysophospholipid signaling integrates with other GPCR-mediated pathways, helping to elucidate the complex network of interactions that regulate cellular responses to environmental stimuli. The study of P2ry10 inhibitors deepens our understanding of the role of lysophospholipid receptors in maintaining cellular organization and signal transduction, offering valuable information about how these pathways contribute to various physiological processes.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Actinomycin D

50-76-0sc-200906
sc-200906A
sc-200906B
sc-200906C
sc-200906D
5 mg
25 mg
100 mg
1 g
10 g
$74.00
$243.00
$731.00
$2572.00
$21848.00
53
(3)

Actinomycin D intercalates into DNA and inhibits RNA synthesis, potentially impacting the transcription of P2Y receptor family member 10.

Cycloheximide

66-81-9sc-3508B
sc-3508
sc-3508A
100 mg
1 g
5 g
$41.00
$84.00
$275.00
127
(6)

Cycloheximide inhibits protein synthesis by interfering with translocation, potentially leading to reduced expression of P2Y receptor family member 10 at the translational level.

Puromycin

53-79-2sc-205821
sc-205821A
10 mg
25 mg
$166.00
$322.00
436
(1)

Puromycin causes premature chain termination during protein synthesis, potentially leading to reduced expression of P2Y receptor family member 10 and other proteins.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$67.00
$223.00
$425.00
97
(3)

Wortmannin inhibits protein phosphorylation and may impact the signaling pathways that regulate the expression of P2Y receptor family member 10.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

Rapamycin inhibits mTOR, a kinase involved in protein synthesis, potentially impacting the translational regulation of P2Y receptor family member 10.

Tunicamycin

11089-65-9sc-3506A
sc-3506
5 mg
10 mg
$172.00
$305.00
66
(3)

Tunicamycin inhibits N-linked glycosylation of proteins, potentially affecting the folding and trafficking of P2Y receptor family member 10.

Fluorouracil

51-21-8sc-29060
sc-29060A
1 g
5 g
$37.00
$152.00
11
(1)

5-Fluorouracil inhibits thymidylate synthase, an enzyme involved in DNA synthesis, potentially impacting the transcription of P2Y receptor family member 10.

Anisomycin

22862-76-6sc-3524
sc-3524A
5 mg
50 mg
$99.00
$259.00
36
(2)

Anisomycin inhibits protein and DNA synthesis, potentially impacting the translational and transcriptional regulation of P2Y receptor family member 10.

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$135.00
$1085.00
115
(2)

Bortezomib inhibits the proteasome, the cellular complex responsible for degrading proteins, potentially impacting the degradation of P2Y receptor family member 10.

Erlotinib, Free Base

183321-74-6sc-396113
sc-396113A
sc-396113B
sc-396113C
sc-396113D
500 mg
1 g
5 g
10 g
100 g
$87.00
$135.00
$293.00
$505.00
$3827.00
42
(0)

Erlotinib inhibits the activity of the epidermal growth factor receptor (EGFR), a receptor tyrosine kinase involved in cell signaling, potentially impacting the signaling pathways regulating the expression of P2Y receptor family member 10.